Search Results - "de Ibarguen, Blanca Cantos Sánchez"

Critically Ill Patient Due to Pneumonitis Secondary to the Use of Filgrastim by Vilaplana, Belén Escudero, Gutiérrez, Julia Ruiz, de Ibarguen, Blanca Cantos Sánchez, Manrique, Marta Manso, Guerrero, Amelia Sánchez

“…Filgrastim is a granulocyte colony-stimulating factor commonly used in the prophylaxis and treatment of neutropenia associated with chemotherapy in cancer…”
Get full text

Long‐term outcomes in Hodgkin lymphoma survivors. Temporary trends and comparison with general population by Núñez‐García, Beatriz, Clemente, Mariola Blanco, Sánchez, Juan Cristóbal, Royuela, Ana, Ibargüen, Blanca Cantos Sánchez de, Méndez, Miriam, López‐Ibor, Jorge V., Martínez, Marta, Traseira, Cristina, Garitaonaindia, Yago, Aguado, Ramón, Calvo, Virginia, Torrente, María, Parejo, Consuelo, Provencio, Zaida, Provencio, Mariano

“…The high cure rates of Hodgkin lymphoma (HL) make this oncological disease among those with the greatest number of long‐term survivors. This single‐institution…”
Get full text

Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2– advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial by Salvador Bofill, Javier, Moreno Anton, Fernando, Rodriguez Sanchez, Cesar Augusto, Galve Calvo, Elena, Hernando Melia, Cristina, Ciruelos Gil, Eva Maria, Vidal, Maria, Jiménez-Rodriguez, Begoña, De la Cruz Merino, Luis, Martínez Jañez, Noelia, Villanueva Vazquez, Rafael, de Toro Salas, Ruben, Anton Torres, Antonio, Alvarez Lopez, Isabel Manuela, Gavila Gregori, Joaquin, Quiroga Garcia, Vanesa, Vicente Rubio, Elena, De la Haba-Rodriguez, Juan, Gonzalez-Santiago, Santiago, Diaz Fernandez, Nieves, Barnadas Molins, Agusti, Cantos Sanchez de Ibargüen, Blanca, Delgado Mingorance, Juan Ignacio, Bellet Ezquerra, Meritxell, de Casa, Sonia, Gimeno, Asuncion, Martin, Miguel

“…Breast cancer is the most common malignancy and the second leading cause of cancer-related mortality in Spanish women. Ribociclib in combination with endocrine…”
Get full text

SEOM-GEINO clinical guideline of systemic therapy and management of brain central nervous system metastases (2021) by Martínez-García, María, Servitja Tormo, Sonia, Vilariño Quintela, Noelia, Arance Fernández, Ana, Berrocal Jaime, Alfonso, Cantos Sánchez de Ibargüen, Blanca, Del Barco Berrón, Sonia, García Campelo, Rosario, Gironés Sarrió, Regina, Manuel Sepúlveda-Sánchez, Juan

“…Central nervous system (CNS) dissemination is a severe complication in cancer and a leading cause of cancer-related mortality. Brain metastases (BMs) are the…”
Get full text

Association of Performance Status and Pain in Metastatic Bone Pain Management in the Spanish Clinical Setting by Dómine Gómez, Manuel, Díaz Fernández, Nieves, Cantos Sánchez de Ibargüen, Blanca, Zugazabeitia Olabarría, Luis, Martínez Lozano, Joaquina, Poza de Celis, Raúl, Trujillo Vílchez, Rafael, Peláez Fernández, Ignacio, Capdevila Castillón, Jaume, Traseira Lugilde, Susana, Esteban González, Emilio

“…Introduction Bone metastasis is the most common cause of cancer-related pain, and metastatic bone pain (MBP) is not only severe but also progressive in many…”
Get full text

High-dose Chemotherapy Followed by Autologous and Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Follicular Non-Hodgkin's Lymphoma in the Rituximab Era by Escobar, Ignacio García, de Ibargüen, Blanca Cantos Sánchez, de Juan, Virginia Calvo, Alonso, C. Maximiano, García, Miriam Méndez, Ruíz, Antonio Carlos Sánchez, Pulla, Mariano Provencio

“…High-dose chemotherapy in lymphomas, and mainly non-Hodgkin's lymphomas, has been advancing since the 1970s. This therapeutic strategy is based on the supposed…”
Get full text

Ocular relapse of primary brain lymphoma in immunocompetent patient, treated with intrathecal rituximab by Alonso, Constanza Maximiano, Sánchez Ruiz, Antonio Carlos, Sánchez de Ibargüen, Blanca Cantos, García, Miriam Méndez, Ronco, Isabel S., Pulla, Mariano Provencio

“…Primary brain lymphoma is a rare variant of extranodal non-Hodgkin’s B-cell lymphoma. In >90% of cases, this is diffuse large B-cell lymphoma with CD20…”
Get full text

Risk factors for cardiovascular events in patients treated with immunotherapy by Garitaonaindia, Yago, Blanco, Mariola, Franco, Fernando, Torrente, Maria, Calvo, Virginia, Collazo, Ana, Gonzalez del Alba, Aranzazu, Sanchez, Juan Cristobal, Gutiérrez, Lourdes, Royuela, Ana, Nuñez Garcia, Beatriz, Mendez, Miriam, Hernández, Roberto, Cantos Sanchez de Ibarguen, Blanca, Martinez Cutillas, Marta, Traseira, Cristina, Aguado, Ramon, Visedo Ceballos, Guillermo, Provencio, Mariano

“…e18736 Background: Immunotherapy (IO) is increasingly widespread in current clinical practice; however, little is known about its cardiovascular safety…”
Get full text

Abstract CT212: A phase III randomized study of paclitaxel (T) and trastuzumab (H) versus T, H and lapatinib (L) in first line treatment of HER2+ metastatic breast cancer (MBC) by Crown, John, Jacot, William, Collins, Denis M., Coate, Linda, Saetersdal, Anna, Kennedy, M John, Kelly, Catherine, De Ibarguen, Blanca Cantos Sanchez, Conejero, Raquel Andrés, Costa, Luis, Brito, Margarida, Keane, Maccon, Rovira, Pedro Sanchez, Martin, Miguel, O'Connor, Miriam, Vazquez, Manuel Ramos, Alvarez, Elena, O'Reilly, Seamus, Mattson, Johanna, Lopez, Laura Jolis, Lescure, Alvaro Rodriguez, Blanco, Esperanza, Muino, Coralia Bueno, Moulton, Brian, O'Donovan, Norma, Hernando, Andres, Nolan, Marc, Parker, Imelda, Gullo, Giuseppe, Hennessy, Bryan

“…Background: The addition of H to chemotherapy improved disease outcome in HER2+ MBC. The combination of H and L with chemotherapy improved event free survival…”
Get full text